Kiren Ubhi

3.4k total citations
36 papers, 2.0k citations indexed

About

Kiren Ubhi is a scholar working on Physiology, Neurology and Neurology. According to data from OpenAlex, Kiren Ubhi has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Neurology and 17 papers in Neurology. Recurrent topics in Kiren Ubhi's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Kiren Ubhi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Kiren Ubhi collaborates with scholars based in United States, Germany and Austria. Kiren Ubhi's co-authors include Eliezer Masliah, Edward Rockenstein, Anthony Adame, Michael Mante, Christina Patrick, Chandra Inglis, Phillip A. Low, Brian Spencer, Elvira Valera and Silke Nuber and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kiren Ubhi

36 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiren Ubhi United States 26 1.0k 806 805 590 465 36 2.0k
Virginia M. Lee United States 17 1.1k 1.1× 746 0.9× 1.3k 1.6× 498 0.8× 735 1.6× 28 2.5k
Katrina L. Paumier United States 18 935 0.9× 650 0.8× 727 0.9× 366 0.6× 421 0.9× 27 1.8k
Bruno A. Benítez United States 26 543 0.5× 371 0.5× 926 1.2× 1.1k 1.9× 767 1.6× 67 2.4k
Xinglong Gu United States 22 929 0.9× 921 1.1× 595 0.7× 421 0.7× 694 1.5× 31 2.1k
Isabella Russo Italy 22 692 0.7× 438 0.5× 514 0.6× 509 0.9× 583 1.3× 39 1.5k
Ronald J. Gathagan United States 10 816 0.8× 495 0.6× 1.3k 1.6× 593 1.0× 605 1.3× 12 1.9k
Shun Yu China 26 1.4k 1.4× 839 1.0× 711 0.9× 301 0.5× 562 1.2× 66 2.1k
Ivan Milenković Austria 22 394 0.4× 477 0.6× 537 0.7× 287 0.5× 573 1.2× 49 1.6k
Michal Arbel‐Ornath United States 12 417 0.4× 826 1.0× 735 0.9× 400 0.7× 367 0.8× 16 1.6k
Amadeus Gladbach Australia 12 325 0.3× 848 1.1× 1.5k 1.9× 504 0.9× 739 1.6× 13 2.3k

Countries citing papers authored by Kiren Ubhi

Since Specialization
Citations

This map shows the geographic impact of Kiren Ubhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiren Ubhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiren Ubhi more than expected).

Fields of papers citing papers by Kiren Ubhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiren Ubhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiren Ubhi. The network helps show where Kiren Ubhi may publish in the future.

Co-authorship network of co-authors of Kiren Ubhi

This figure shows the co-authorship network connecting the top 25 collaborators of Kiren Ubhi. A scholar is included among the top collaborators of Kiren Ubhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiren Ubhi. Kiren Ubhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rockenstein, Edward, Paula Desplats, Kiren Ubhi, et al.. (2015). Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease. SHILAP Revista de lepidopterología. 9s2(Suppl 2). 131–40. 6 indexed citations
2.
Rockenstein, Edward, Paula Desplats, Kiren Ubhi, et al.. (2015). Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease. Stem Cell Research. 15(1). 54–67. 38 indexed citations
3.
Games, Dora, Elvira Valera, Brian Spencer, et al.. (2014). Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models. Journal of Neuroscience. 34(28). 9441–9454. 244 indexed citations
4.
Valera, Elvira, Kiren Ubhi, Michael Mante, Edward Rockenstein, & Eliezer Masliah. (2013). Antidepressants reduce neuroinflammatory responses and astroglial alpha‐synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia. 62(2). 317–337. 60 indexed citations
5.
Vázquez‐Roque, Rubén Antonio, Kiren Ubhi, Eliezer Masliah, & Gonzalo Flores. (2013). Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat. Synapse. 68(1). 31–38. 27 indexed citations
6.
Kohl, Zacharias, Beate Winner, Kiren Ubhi, et al.. (2012). Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model. European Journal of Neuroscience. 35(1). 10–19. 86 indexed citations
7.
Ubhi, Kiren & Eliezer Masliah. (2012). Current State of the Art in Preclinical Research in Alzheimer’s Disease - A Focus on Mode of Action in Pharmacological and Non-pharmacological Approaches. European Neurological Review. 7(4). 216–216. 1 indexed citations
8.
Cartier, Anna, Kiren Ubhi, Brian Spencer, et al.. (2012). Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy. PLoS ONE. 7(4). e34713–e34713. 58 indexed citations
9.
Kragh, Christine Lund, et al.. (2011). Autophagy in Dementias. Brain Pathology. 22(1). 99–109. 54 indexed citations
10.
Paulino, Amy, Kiren Ubhi, Edward Rockenstein, et al.. (2011). Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. Journal of NeuroVirology. 17(4). 327–340. 30 indexed citations
11.
Rockenstein, Edward, Kiren Ubhi, Sarah Michael, et al.. (2011). Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease. Journal of Neuroscience Research. 89(11). 1812–1821. 18 indexed citations
12.
Ubhi, Kiren, Edward Rockenstein, Michael Mante, et al.. (2010). Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy. Neuroreport. 21(6). 457–462. 11 indexed citations
13.
Lessig, Stephanie, Kiren Ubhi, Douglas Galasko, et al.. (2010). Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 21(11). 756–760. 33 indexed citations
14.
15.
Ubhi, Kiren, Edward Rockenstein, Michael Mante, et al.. (2010). Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors. Journal of Neuroscience. 30(18). 6236–6246. 125 indexed citations
16.
Ubhi, Kiren, Edward Rockenstein, Edith Doppler, et al.. (2009). Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin. Acta Neuropathologica. 117(6). 699–712. 34 indexed citations
17.
Cowan, Catherine M., et al.. (2009). Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Experimental Neurology. 223(2). 401–409. 74 indexed citations
18.
Ubhi, Kiren, Phil Hyu Lee, Anthony Adame, et al.. (2009). Mitochondrial inhibitor 3‐nitroproprionic acid enhances oxidative modification of alpha‐synuclein in a transgenic mouse model of multiple system atrophy. Journal of Neuroscience Research. 87(12). 2728–2739. 61 indexed citations
19.
Ubhi, Kiren, Edward Rockenstein, Michael Mante, et al.. (2008). Rifampicin reduces α-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport. 19(13). 1271–1276. 55 indexed citations
20.
Ubhi, Kiren, et al.. (2007). A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Invertebrate Neuroscience. 7(3). 165–171. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia M. Lee Breakdown of academic impact, for papers by Katrina L. Paumier Breakdown of academic impact, for papers by Bruno A. Benítez Breakdown of academic impact, for papers by Xinglong Gu Breakdown of academic impact, for papers by Isabella Russo Breakdown of academic impact, for papers by Ronald J. Gathagan Breakdown of academic impact, for papers by Shun Yu Breakdown of academic impact, for papers by Ivan Milenković Breakdown of academic impact, for papers by Michal Arbel‐Ornath Breakdown of academic impact, for papers by Amadeus Gladbach
Rankless by CCL
2026